CS logo
small CS logo
Marienkrankenhaus Schwerte

Schwerte, Germany

About Marienkrankenhaus Schwerte


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Marienkrankenhaus Schwerte


During the past decade, Marienkrankenhaus Schwerte conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Marienkrankenhaus Schwerte" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

Clinical Trials Conditions at Marienkrankenhaus Schwerte


According to Clinical.Site data, the most researched conditions in "Marienkrankenhaus Schwerte" are "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Marienkrankenhaus Schwerte" in a lesser frequency.

Clinical Trials Intervention Types at Marienkrankenhaus Schwerte


Most popular intervention types in "Marienkrankenhaus Schwerte" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel / cyclophosphamide" (1 trials), "Palbociclib" (1 trials), "Palbociclib + endocrine therapy" (1 trials), "doxorubicin/cyclophosphamide" (1 trials) and "epirubicin/cyclophosphamide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Marienkrankenhaus Schwerte


The vast majority of trials in "Marienkrankenhaus Schwerte" are 2 trials for "All" genders.

Clinical Trials Status at Marienkrankenhaus Schwerte


Currently, there are NaN active trials in "Marienkrankenhaus Schwerte". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marienkrankenhaus Schwerte, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Marienkrankenhaus Schwerte, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".